Over the years, the global effort to eliminate cervical cancer has focused on the HPV vaccine introduced in 2007, which aims to protect against this common virus.
Cervical cancer, caused by HPV, impacts primarily women aged 35 to 44, with over 350,000 deaths occurring annually, mostly in low- to middle-income countries.
In light of healthcare access issues, WHO recommended a single dose of the HPV vaccine in 2022 to help increase immunization rates globally.
The recent Global Cervical Cancer Elimination Forum aimed to boost efforts and funding, with organizations pledging $600 million to combat cervical cancer worldwide.
Collection
[
|
...
]